SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

Feb 7 2024
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID , Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Junior Sales Operations Specialist Intern France Clinical Sales
Junior Bioinformation Intern - Tertiary Analysis Switzerland Data Science
Junior Customer Services Specialist Intern Switzerland Clinical Sales
Accounts Payable Accountant France Finance
NGS Sales Manager - ANZ Australia Clinical Sales